GoodRx Holdings, Inc. (GDRX) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Goodrx Holdings, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.136 or uninsured, we are here to help them access and afford the full range of prescriptions 00:00:05.136 -- 00:00:07.978 they need to stay healthy. Turning 00:00:07.978 -- 00:00:13.103 to our third quarter performance, we delivered solid financial results driven by discipline 00:00:13.103 -- 00:00:18.128 execution. While we're pleased with our overall momentum, we have continued to navigate 00:00:18.128 -- 00:00:21.811 industry headwinds that have modestly impacted our results. 00:00:21.811 -- 00:00:26.335 The ongoing and now complete Rite Aid store closures reduce prescription volume across 00:00:26.335 -- 00:00:31.547 certain geographies. We are actively working to recapture displaced users, both 00:00:31.547 -- 00:00:36.293 through direct communications where available and in partnership with acquiring pharmacy 00:00:36.293 -- 00:00:41.198 retailers. But as we noted on the last call, this takes some time. 00:00:41.198 -- 00:00:46.124 As always, we remain focused on the long-term health and growth of the business and creating 00:00:46.124 -- 00:00:50.830 lasting value for our consumers, partners, and shareholders alike. 00:00:50.830 -- 00:00:56.393 Now let's dive into key business updates. Starting with pharma manufacturer solutions, 00:00:56.393 -- 00:01:01.240 which we'll refer to as manufacturer solutions, we delivered strong results during the 00:01:01.240 -- 00:01:05.806 third quarter with 54% year-over-year revenue growth. 00:01:05.806 -- 00:01:11.434 We continue to sell new brands and expand relationships with existing partners, reinforcing 00:01:11.434 -- 00:01:16.681 our position as the go-to partner for manufacturers seeking to improve access and affordability 00:01:16.681 -- 00:01:20.366 for patients. Our value propositio...